-
公开(公告)号:KR1020090102317A
公开(公告)日:2009-09-30
申请号:KR1020080027677
申请日:2008-03-26
Applicant: 아주대학교산학협력단
CPC classification number: A61K38/1709 , A61K48/00 , C07K14/47
Abstract: PURPOSE: An anticancer containing RB1CC1 protein or Rb1cc1 gene is provided to suppress carcinogenesis and transcription of cancer-related gene. CONSTITUTION: An anticancer drug comprises RB1CC1(RB1-inducible Coiled-Coil 1) protein as an active ingredient. The anticancer drug also comprises Rb1cc1(RB1-inducible Coiled-Coil 1) gene. The cancer is a beta-catenin protein or gene-mediated cancer.
Abstract translation: 目的:提供含有RB1CC1蛋白或Rb1cc1基因的抗癌剂,以抑制癌相关基因的致癌和转录。 构成:抗癌药物含有作为活性成分的RB1CC1(RB1诱导性盘绕线圈1)蛋白质。 抗癌药物还包含Rb1cc1(RB1诱导型卷绕线圈1)基因。 癌症是β-连环蛋白或基因介导的癌症。